Waveform analysis of tremor may help to differentiate Parkinson's disease from drug-induced parkinsonism

Physiological Measurement

Volumn 34, Issue 3, 2013, Pages

  Jang, W ^a,b   Han, J ^b   Park, J ^c   Kim, J S ^d   Cho, J W ^e   Koh, S B ^f   Chung, S J ^a   Kim, I Y ^b   Kim, H T ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

^e Samsung Medical Center   (South Korea)

^f Korea University College of Medicine   (South Korea)

Author keywords

accelerometry; drug induced parkinsonism; Parkinsons disease; tremor

Indexed keywords

AUTOCORRELATION; HARMONIC ANALYSIS; NEURODEGENERATIVE DISEASES; WAVEFORM ANALYSIS;

ACCELEROMETRY; AUTOCORRELATION FUNCTIONS; DRUG-INDUCED PARKINSONISM; HARMONIC PEAKS; MATHEMATICAL ALGORITHMS; PARKINSON'S DISEASE; PEAK FREQUENCIES; TIME-REVERSAL INVARIANCE; TREMOR; WAVEFORM CHARACTERISTICS;

ACCELEROMETERS;

EID: 84874451915     PISSN: 09673334     EISSN: 13616579     Source Type: Journal    
DOI: 10.1088/0967-3334/34/3/N15     Document Type: Article

References (26)

1. Bergman H and Deuschl G 2002 Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back Mov. Disord. 17 S28-40
2. Blesic S, Maric J, Dragasevic N, Milanovic S, Kostic V and Ljubisavljevic M 2011 Scaling analysis of bilateral hand tremor movements in essential tremor patients J. Neural Transm. 118 1227-34
3. Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O and Montastruc J-L 2011 Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France Mov. Disord. 26 2226-31
4. Burn D J and Brooks D J 1993 Nigral dysfunction in drug-induced parkinsonism Neurology 43 552-6
5. Deuschl G, Krack P, Lauk M and Timmer J 1996 Clinical neurophysiology of tremor J. Clin. Neurophysiol. 13 110-21
6. Deuschl G, Lauk M and Timmer J 1995 Tremor classification and tremor time series analysis Chaos 5 48-51
7. Deuschl G, Raethjen J, Baron R, Lindemann M, Wilms H and Krack P 2000 The pathophysiology of parkinsonian tremor: a review J. Neurol. 247 V33-48
8. Diaz-Corrales F J, Sanz-Viedma S, Garcia-Solis D, Escobar-Delgado T and Mir P 2010 Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease Eur. J. Nucl. Med. Mol. Imaging 37 556-64
9. Fishman P S 2008 Paradoxical aspects of parkinsonian tremor Mov. Disord. 23 168-73
10. Gresty M and Buckwell D 1990 Spectral analysis of tremor: understanding the results J. Neurol. Neurosurg. Psychiatry 53 976-981
11. Hallett M and Deuschl G 2010 Are we making progress in the understanding of tremor in Parkinson's disease? Ann. Neurol. 68 780-1
12. Halliday D M, Rosenberg J R, Amjad A M, Breeze P, Conway B A and Farmer S F 1995 A framework for the analysis of mixed time series/point process data - Theory and application to the study of physiological tremor, single motor unit discharges and electromyograms Prog. Biophys. Mol. Biol. 64 237-78
13. Hassin-Baer S, Sirota P, Korczyn A D, Treves T A, Epstein B, Shabtai H, Martin T, Litvinjuk Y and Giladi N 2001 Clinical characteristics of neuroleptic-induced parkinsonism J. Neural Transm. 108 1299-308
14. Kim J-S, Oh Y-S, Kim Y-I, Yang D-W, Chung Y-A, You I-R and Lee K-S 2013 Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): A 2-year follow-up study Arch. Gerontol. Geriatr. 56 124-8
15. Lauk M, Timmer J, Lücking C H, Honerkamp J and Deuschl G 1999 A software for recording and analysis of human tremor Comput. Methods Programs Biomed. 60 65-77
16. Lee P H, Kim J S, Shin D H, Yoon S-N and Huh K 2006 Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism J. Neurol. Neurosurg. Psychiatry 77 372-4
17. Lorberboym M, Treves T A, Melamed E, Lampl Y, Hellmann M and Djaldetti R 2006 [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease Mov. Disord. 21 510-4
18. Mena M A and de Yébenes J G 2006 Drug-induced parkinsonism Expert Opin. Drug Saf. 5 759-71
19. Milanov I 2001 Electromyographic differentiation of tremors Clin. Neurophysiol. 112 1626-32
20. Muthuraman M, Hossen A, Heute U, Deuschl G and Raethjen J 2011 A new diagnostic test to distinguish tremulous Parkinson's disease from advanced essential tremor Mov. Disord. 26 1548-52
21. Raethjen J, Govindan R B, Muthuraman M, Kopper F, Volkmann J and Deuschl G 2009 Cortical correlates of the basic and first harmonic frequency of Parkinsonian tremor Clin. Neurophysiol. 120 1866-72
22. Shaikh A G, Jinnah H A, Tripp R M, Optican L M, Ramat S, Lenz F A and Zee D S 2008 Irregularity distinguishes limb tremor in cervical dystonia from essential tremor J. Neurol. Neurosurg. Psychiatry 79 187-9
23. Shinozaki H 1984 Quantitative analysis of drug-induced tremor in mice Neurosci. Res. 2 63-76
24. Thanvi B and Treadwell S 2009 Drug induced parkinsonism: a common cause of parkinsonism in older people Postgrad. Med. J. 85 322-6
25. Tinazzi M, Antonini A, Bovi T, Pasquin I, Steinmayr M, Moretto G, Fiaschi A and Ottaviani S 2009 Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism J. Neurol. 256 910-5
26. Wang S, Aziz T Z, Stein J F, Bain P G and Liu X 2006 Physiological and harmonic components in neural and muscular coherence in Parkinsonian tremor Clin. Neurophysiol. 117 1487-98